Clinical Trial Update: Efficacy and Safety of CAR-T Cells Therapy for Chronic or Refractory Primary Immune Thrombocytopenia (ITP) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating the safety and efficacy of CAR-T cell therapy for chronic or refractory primary immune thrombocytopenia and is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• CAR-T cell therapy

Snippet

Sponsor: 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China | Conditions: ITP - Immune Thrombocytopenia | Phase 1, Phase 2 | Status: RECRUITING